Gyre Therapeutics, Inc.GYRENASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+6.3%
5Y CAGR+39.7%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+6.3%/yr
vs +55.2%/yr prior
5Y CAGR
+39.7%/yr
Recent deceleration
Acceleration
-48.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $85.98M | +16.8% |
| 2024 | $73.62M | -2.9% |
| 2023 | $75.82M | +5.9% |
| 2022 | $71.61M | +280.5% |
| 2021 | $18.82M | +16.3% |
| 2020 | $16.18M | +21.9% |
| 2019 | $13.27M | +7.4% |
| 2018 | $12.35M | +23.6% |
| 2017 | $9.99M | +7.9% |
| 2016 | $9.26M | - |